Inactivation of the dorsal or ventral hippocampus with muscimol differentially affects fear and memory

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

It was recently found that temporary inactivation of the dorsal hippocampus with lidocaine impaired fear memory, whereas temporary inactivation of the ventral hippocampus did not. These site-specific deficits, however, may have resulted from disruption of axonal signals arriving from structures outside of the hippocampus, or from disruption of axons that pass through the hippocampus entirely. This is problematic because the hippocampus receives extensive afferent input from both the amygdala and the septum, which also play very important roles in fear and fear memory. To mitigate this problem, rats were infused with the GABAA receptor agonist muscimol, into either the dorsal or the ventral hippocampus, just after an "acquisition" session in which the rats were shocked from an electrified probe. A "retention" test in the same apparatus was conducted 24 h later, when the hippocampus was no longer inactivated, and the probe was no longer electrified. Dorsal hippocampal inactivation just after acquisition impaired conditioned fear behavior (probe avoidance) during the retention test, whereas ventral hippocampal inactivation after acquisition did not. However, muscimol inactivation of the ventral hippocampus during an "acquisition" session selectively impaired unconditioned fear behavior, replicating earlier findings with lidocaine, a sodium channel blocker. Because muscimol hyperpolarizes neurons through a post-synaptic, GABAA receptor-mediated increase of chloride conductance-whereas lidocaine produces indiscriminate disruption of all axonal signalling-its effects are more likely to be restricted to intrinsic neurons within the area of infusion. These results provide strong evidence that afferent input from brain structures located outside of the hippocampus is not responsible for the differential effects of dorsal and ventral hippocampal inactivation on fear memory.

Original languageEnglish
Pages (from-to)145-151
Number of pages7
JournalBrain Research
Volume1353
DOIs
Publication statusPublished - 2010 Sep 24
Externally publishedYes

Fingerprint

Muscimol
Fear
Hippocampus
Lidocaine
Sodium Channel Blockers
GABA-A Receptor Agonists
Avoidance Learning
Neurons
Neurotransmitter Receptor
GABA-A Receptors
Amygdala
Axons
Chlorides

Keywords

  • Dorsal
  • Fear memory
  • Fear response
  • Functional dissociation
  • Hippocampus
  • Muscimol
  • Ventral

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Inactivation of the dorsal or ventral hippocampus with muscimol differentially affects fear and memory. / McEown, Kristopher Scott; Treit, Dallas.

In: Brain Research, Vol. 1353, 24.09.2010, p. 145-151.

Research output: Contribution to journalArticle

@article{481203f273b54381aef74974d14c8ec4,
title = "Inactivation of the dorsal or ventral hippocampus with muscimol differentially affects fear and memory",
abstract = "It was recently found that temporary inactivation of the dorsal hippocampus with lidocaine impaired fear memory, whereas temporary inactivation of the ventral hippocampus did not. These site-specific deficits, however, may have resulted from disruption of axonal signals arriving from structures outside of the hippocampus, or from disruption of axons that pass through the hippocampus entirely. This is problematic because the hippocampus receives extensive afferent input from both the amygdala and the septum, which also play very important roles in fear and fear memory. To mitigate this problem, rats were infused with the GABAA receptor agonist muscimol, into either the dorsal or the ventral hippocampus, just after an {"}acquisition{"} session in which the rats were shocked from an electrified probe. A {"}retention{"} test in the same apparatus was conducted 24 h later, when the hippocampus was no longer inactivated, and the probe was no longer electrified. Dorsal hippocampal inactivation just after acquisition impaired conditioned fear behavior (probe avoidance) during the retention test, whereas ventral hippocampal inactivation after acquisition did not. However, muscimol inactivation of the ventral hippocampus during an {"}acquisition{"} session selectively impaired unconditioned fear behavior, replicating earlier findings with lidocaine, a sodium channel blocker. Because muscimol hyperpolarizes neurons through a post-synaptic, GABAA receptor-mediated increase of chloride conductance-whereas lidocaine produces indiscriminate disruption of all axonal signalling-its effects are more likely to be restricted to intrinsic neurons within the area of infusion. These results provide strong evidence that afferent input from brain structures located outside of the hippocampus is not responsible for the differential effects of dorsal and ventral hippocampal inactivation on fear memory.",
keywords = "Dorsal, Fear memory, Fear response, Functional dissociation, Hippocampus, Muscimol, Ventral",
author = "McEown, {Kristopher Scott} and Dallas Treit",
year = "2010",
month = "9",
day = "24",
doi = "10.1016/j.brainres.2010.07.030",
language = "English",
volume = "1353",
pages = "145--151",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Inactivation of the dorsal or ventral hippocampus with muscimol differentially affects fear and memory

AU - McEown, Kristopher Scott

AU - Treit, Dallas

PY - 2010/9/24

Y1 - 2010/9/24

N2 - It was recently found that temporary inactivation of the dorsal hippocampus with lidocaine impaired fear memory, whereas temporary inactivation of the ventral hippocampus did not. These site-specific deficits, however, may have resulted from disruption of axonal signals arriving from structures outside of the hippocampus, or from disruption of axons that pass through the hippocampus entirely. This is problematic because the hippocampus receives extensive afferent input from both the amygdala and the septum, which also play very important roles in fear and fear memory. To mitigate this problem, rats were infused with the GABAA receptor agonist muscimol, into either the dorsal or the ventral hippocampus, just after an "acquisition" session in which the rats were shocked from an electrified probe. A "retention" test in the same apparatus was conducted 24 h later, when the hippocampus was no longer inactivated, and the probe was no longer electrified. Dorsal hippocampal inactivation just after acquisition impaired conditioned fear behavior (probe avoidance) during the retention test, whereas ventral hippocampal inactivation after acquisition did not. However, muscimol inactivation of the ventral hippocampus during an "acquisition" session selectively impaired unconditioned fear behavior, replicating earlier findings with lidocaine, a sodium channel blocker. Because muscimol hyperpolarizes neurons through a post-synaptic, GABAA receptor-mediated increase of chloride conductance-whereas lidocaine produces indiscriminate disruption of all axonal signalling-its effects are more likely to be restricted to intrinsic neurons within the area of infusion. These results provide strong evidence that afferent input from brain structures located outside of the hippocampus is not responsible for the differential effects of dorsal and ventral hippocampal inactivation on fear memory.

AB - It was recently found that temporary inactivation of the dorsal hippocampus with lidocaine impaired fear memory, whereas temporary inactivation of the ventral hippocampus did not. These site-specific deficits, however, may have resulted from disruption of axonal signals arriving from structures outside of the hippocampus, or from disruption of axons that pass through the hippocampus entirely. This is problematic because the hippocampus receives extensive afferent input from both the amygdala and the septum, which also play very important roles in fear and fear memory. To mitigate this problem, rats were infused with the GABAA receptor agonist muscimol, into either the dorsal or the ventral hippocampus, just after an "acquisition" session in which the rats were shocked from an electrified probe. A "retention" test in the same apparatus was conducted 24 h later, when the hippocampus was no longer inactivated, and the probe was no longer electrified. Dorsal hippocampal inactivation just after acquisition impaired conditioned fear behavior (probe avoidance) during the retention test, whereas ventral hippocampal inactivation after acquisition did not. However, muscimol inactivation of the ventral hippocampus during an "acquisition" session selectively impaired unconditioned fear behavior, replicating earlier findings with lidocaine, a sodium channel blocker. Because muscimol hyperpolarizes neurons through a post-synaptic, GABAA receptor-mediated increase of chloride conductance-whereas lidocaine produces indiscriminate disruption of all axonal signalling-its effects are more likely to be restricted to intrinsic neurons within the area of infusion. These results provide strong evidence that afferent input from brain structures located outside of the hippocampus is not responsible for the differential effects of dorsal and ventral hippocampal inactivation on fear memory.

KW - Dorsal

KW - Fear memory

KW - Fear response

KW - Functional dissociation

KW - Hippocampus

KW - Muscimol

KW - Ventral

UR - http://www.scopus.com/inward/record.url?scp=77956394829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956394829&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2010.07.030

DO - 10.1016/j.brainres.2010.07.030

M3 - Article

VL - 1353

SP - 145

EP - 151

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -